ID: ALA77611

Max Phase: Preclinical

Molecular Formula: C24H33NO9

Molecular Weight: 479.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C1(O)C(OC(=O)c2ccc[nH]2)C2(O)C3(C)CC4(O)OC5(CC(O)CCC35O)C2(O)C41C

Standard InChI:  InChI=1S/C24H33NO9/c1-12(2)22(30)16(33-15(27)14-6-5-9-25-14)23(31)17(3)11-21(29)18(22,4)24(23,32)20(34-21)10-13(26)7-8-19(17,20)28/h5-6,9,12-13,16,25-26,28-32H,7-8,10-11H2,1-4H3

Standard InChI Key:  WMQJRIRLNCVUDB-UHFFFAOYSA-N

Associated Targets(non-human)

Ryanodine receptor 1 126 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ryanodine receptor 3 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ryanodine receptor 2 12 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 479.53Molecular Weight (Monoisotopic): 479.2155AlogP: -0.43#Rotatable Bonds: 3
Polar Surface Area: 172.70Molecular Species: NEUTRALHBA: 9HBD: 7
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.24CX Basic pKa: CX LogP: -0.65CX LogD: -0.65
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.28Np Likeness Score: 2.31

References

1. Jefferies PR, Gengo PJ, Watson MJ, Casida JE..  (1996)  Ryanodine action at calcium release channels. 2. relation to substituents of the cyclohexane ring.,  39  (12): [PMID:8691428] [10.1021/jm950712d]

Source